Millennium Management’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.52M Sell
1,294,574
-478,965
-27% -$1.72M ﹤0.01% 3067
2025
Q4
$6.07M Sell
1,773,539
-656,197
-27% -$2.93M ﹤0.01% 2801
2025
Q3
$12.2M Sell
2,429,736
-967,853
-28% -$4.27M 0.01% 2182
2025
Q2
$11.7M Buy
3,397,589
+2,527,880
+291% +$6.29M 0.01% 2101
2025
Q1
$1.94M Sell
869,709
-613,006
-41% -$1.76M ﹤0.01% 3810
2024
Q4
$4.34M Buy
1,482,715
+728,828
+97% +$2.03M ﹤0.01% 2945
2024
Q3
$1.96M Buy
753,887
+303,197
+67% +$840K ﹤0.01% 3716
2024
Q2
$1.33M Sell
450,690
-817,328
-64% -$3.09M ﹤0.01% 3878
2024
Q1
$5.74M Buy
1,268,018
+12,799
+1% +$65.3K ﹤0.01% 2733
2023
Q4
$7.17M Sell
1,255,219
-266,060
-17% -$1.23M 0.01% 2484
2023
Q3
$7M Sell
1,521,279
-1,746,339
-53% -$10.6M 0.01% 2394
2023
Q2
$21.1M Buy
3,267,618
+2,060,920
+171% +$14.1M 0.02% 1339
2023
Q1
$9.1M Buy
1,206,698
+779,150
+182% +$7.08M 0.01% 2057
2022
Q4
$4.33M Sell
427,548
-441,756
-51% -$5.1M ﹤0.01% 2937
2022
Q3
$8.6M Sell
869,304
-2,087,340
-71% -$22.9M 0.01% 2332
2022
Q2
$31.5M Buy
2,956,644
+1,462,648
+98% +$12.4M 0.04% 919
2022
Q1
$14.6M Buy
1,493,996
+797,635
+115% +$7.55M 0.02% 1722
2021
Q4
$9.96M Sell
696,361
-151,458
-18% -$2.3M 0.01% 2148
2021
Q3
$17M Buy
847,819
+782,162
+1,191% +$13.8M 0.02% 1471
2021
Q2
$1.44M Buy
65,657
+41,269
+169% +$1.14M ﹤0.01% 4306
2021
Q1
$828K Sell
24,388
-72,168
-75% -$2.87M ﹤0.01% 4389
2020
Q4
$3.88M Buy
+96,556
New +$4.42M 0.01% 2688

Other funds holding ABCL